Instadose Pharma (Instadose Pharma) Inventory-to-Revenue : 0.00 (As of Feb. 2022)

View and export this data going back to 2019. Start your Free Trial

What is Instadose Pharma Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Instadose Pharma's Average Total Inventories for the quarter that ended in Feb. 2022 was $0.00 Mil. Instadose Pharma's Revenue for the three months ended in Feb. 2022 was $0.00 Mil.

Instadose Pharma's Inventory-to-Revenue for the quarter that ended in Feb. 2022 stayed the same from Nov. 2021 (0.00) to Nov. 2021 (0.00)

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Instadose Pharma Inventory-to-Revenue Historical Data

The historical data trend for Instadose Pharma's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Instadose Pharma Inventory-to-Revenue Chart

Instadose Pharma Annual Data

Trend

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Inventory-to-Revenue

Get a 7-Day Free Trial

Instadose Pharma Quarterly Data
	May17	Aug17	Nov17	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22
Inventory-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Instadose Pharma's Inventory-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Instadose Pharma's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Instadose Pharma's Inventory-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Instadose Pharma's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Instadose Pharma's Inventory-to-Revenue falls into.

Instadose Pharma Inventory-to-Revenue Calculation

Instadose Pharma's Inventory-to-Revenue for the fiscal year that ended in Nov. 2021 is calculated as

	Inventory-to-Revenue (A: Nov. 2021 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (A: Nov. 2020 )	+	Total Inventories (A: Nov. 2021 ))	/	count )	/	Revenue (A: Nov. 2021 )
=	( (0	+	0)	/	1 )	/	0
=	0					/	0
=	N/A

Instadose Pharma's Inventory-to-Revenue for the quarter that ended in Feb. 2022 is calculated as

	Inventory-to-Revenue (Q: Feb. 2022 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (Q: Nov. 2021 )	+	Total Inventories (Q: Feb. 2022 ))	/	count )	/	Revenue (Q: Feb. 2022 )
=	( (0	+	0)	/	1 )	/	0
=	0					/	0
=

Instadose Pharma (OTCPK:INSD) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Instadose Pharma's Days Inventory for the three months ended in Feb. 2022 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Feb. 2022 )	/	Cost of Goods Sold (Q: Feb. 2022 )	*	Days in Period
	=	0	/	0	*	365 / 4
	=

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Instadose Pharma's Inventory Turnover for the quarter that ended in Feb. 2022 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Feb. 2022 )	/	Average Total Inventories (Q: Feb. 2022 )
	=	0	/	0
	=

Instadose Pharma Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Instadose Pharma's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Instadose Pharma (Instadose Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Instadose Pharma Corp (OTCPK:INSD) » Definitions » Inventory-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

5500 North Service Road, Suite 301, Burlington, ON, CAN, L7L 6W6

Website

https://www.instadosepharma.com

Instadose Pharma Corp, formerly Mikrocoze Inc is seeking to create a global distribution platform for medicinal cannabis and cannabinoid oil. The company endeavors to utilize the Global Distribution Platform to open the commercial gateway to a new wholesale marketplace along with providing pharmaceutical industry companies with large, sustainable, consistent, diverse, and low?cost supplies of high?quality medicinal cannabis and cannabinoid oil for use in bulk as an active pharmaceutical ingredient.